Hudson Bay Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101M Buy
+280,000
New +$95.8M 0.28% 82
2025
Q3
Sell
-93,600
Closed -$26.1M 1231
2025
Q2
$26.1M Sell
93,600
-431,200
-82% -$122M 0.09% 172
2025
Q1
$164M Buy
+524,800
New +$155M 0.5% 40
2019
Q1
Sell
-35,000
Closed -$6.81M 686
2018
Q4
$6.81M Sell
35,000
-5,000
-13% -$975K 0.09% 212
2018
Q3
$8.29M Sell
40,000
-21,700
-35% -$4.28M 0.1% 183
2018
Q2
$11.4M Buy
61,700
+18,000
+41% +$3.18M 0.16% 123
2018
Q1
$7.45M Buy
+43,700
New +$8.02M 0.15% 156

Other funds holding AMGN

Hudson Bay Capital Management's AMGN Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 281,000 shares worth $102M. The stake represents 0.28% of the portfolio and ranks #81 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in AMGN as recently as Q2 2025.

Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and has held it in 12 quarters since. 3,154 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hudson Bay Capital Management held 281,000 shares of Amgen worth $102M as of Q2 2026.
  • Amgen was a new Hudson Bay Capital Management position in Q2 2026.
  • Amgen made up 0.28% of Hudson Bay Capital Management's portfolio in Q2 2026, its #81 holding.
  • Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and has held it in 12 quarters since.
  • 3,154 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.